Statins and therapy of Alzheimer's disease: Questions of effi cacy versus trial design

Alzheimer's Research and Therapy

Volumn 4, Issue , 2012, Pages

  Wolozin, Benjamin ^a,b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Center for Health Quality Outcomes and Economic Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; SIMVASTATIN;

AGING; ALZHEIMER DISEASE; CARDIOVASCULAR DISEASE; DRUG EFFICACY; HUMAN; INFLAMMATION; NERVE CELL PLASTICITY; PRIORITY JOURNAL; REVIEW; STUDY DESIGN;

EID: 83455203144     PISSN: None     EISSN: 17589193     Source Type: Journal    
DOI: 10.1186/alzrt101     Document Type: Review

References (17)

1. Wolozin B, Kellman W, Ruosseau P, Celesia GG, Siegel G: Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Arch Neurol 2000, 57:1439-1443.
2. Wolozin B, Manger J, Bryant R, Cordy J, Green RC, McKee A: Re-Assessing the relationship between cholesterol, statins and Alzheimer?s disease. Acta Neurol Scand Suppl 2006, 185:63-70.
3. Zandi PP, Sparks DL, Khachaturian AS, Tschanz J, Norton M, Steinberg M, Welsh-Bohmer KA, Breitner JC; Cache County Study investigators: Do statins reduce risk of incident dementia and AD? The Cache County Study. Arch Gen Psychiatry 2004, 62:217-224.
4. Sjogren M, Mielke M, Gustafson D, Zandi P, Skoog I: Cholesterol and Alzheimer?s disease-is there a relation? Mech Ageing Dev 2006, 127:138-147.
5. Rea TD, Breitner JC, Psaty BM, Fitzpatrick AL, Lopez OL, Newman AB, Hazzard WR, Zandi PP, Burke GL, Lyketsos CG, Bernick C, Kuller LH: Statin use and the risk of incident dementia: The Cardiovascular Health Study. Arch Neurol 2005, 62:1047-1051.
6. Green RC, McNagny SE, Jayakumar P, Cupples LA, Benke K, Farrer LA: Statin use and the risk of Alzheimer?s disease. Alzheimer?s & Dementia 2006, 2:96-1003.
7. Li G, Higdon R, Kukull WA, Peskind E, Van Valen Moore K, Tsuang D, van Belle G, McCormick W, Bowen JD, Teri L, Schellenberg GD, Larson EB: Statin therapy and risk of dementia in the elderly: A community-based prospective cohort study. Neurology 2004, 63:1624-1628.
8. Li G, Larson EB, Sonnen JA, Shofer JB, Petrie EC, Schantz A, Peskind ER, Raskind MA, Breitner JC, Montine TJ: Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease. Neurology 2007, 69:878-885.
9. Masse I, Bordet R, Deplanque D, Al Khedr A, Richard F, Libersa C, Pasquier F: Lipid lowering agents are associated with a slower cognitive decline in Alzheimer?s disease. J Neurol Neurosurg Psychiatry 2005, 76:1624-1629.
10. Rockwood K, Kirkland S, Hogan DB, MacKnight C, Merry H, Verreault R, Wolfson C, McDowell I: Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people. Arch Neurol 2002, 59:223-227.
11. Zhou B, Teramukai S, Fukushima M: Prevention and treatment of dementia or Alzheimer?s disease by statins: A meta-Analysis. Dement Geriatr Cogn Disord 2007, 23:194-201.
12. Feldman HH, Doody RS, Kivipelto M, Sparks DL, Waters DD, Jones RW, Schwam E, Schindler R, Hey-Hadavi J, DeMicco DA, Breazna A: Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe. Neurology 2010, 74:956-964.
13. Sano M, Bell KL, Galasko D, Galvin JE, Thomas RG, van Dyck CH, Aisen PS: A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease. Neurology 2010, 77:556-563.
14. Mangialasche F, Solomon A, Winblad B, Mecocci P, Kivipelto M: Alzheimer?s disease: clinical trials and drug development. Lancet Neurol 2010, 9:702-716.
15. Vega GL, Weiner MF, Lipton AM, Von Bergmann K, Lutjohann D, Moore C, Svetlik D: Reduction in levels of 24S-hydroxycholesterol by statin treatment in patients with Alzheimer disease. Arch Neurol 2003, 60:510-515.
16. Li NC, Lee A, Whitmer RA, Kivipelto M, Lawler E, Kazis LE, Wolozin B: Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis. BMJ 2010, 340:b5465.
17. Van Dyke TE: Proresolving lipid mediators: potential for prevention and treatment of periodontitis. J Clin Periodontol 2011, 38 Suppl 11:119-125.